The invention relates to therapeutic peptides and uses thereof. In particular, the invention relates to disulphide-linked homodimers comprising CQQYNSYPLT monomers useful in the treatment or prevention of hyperinsulinaemia, hyperglucagonaemia, glucose intolerance, insulin resistance or diabetes in human subjects, via oral transmucosal administration.